Safety Concerns Halt Rabies Vaccine Production in Shenzhen

By Jessica Ho, July 18, 2018

0 0

Changsheng Life Sciences Shenzhen and its Jilin province off-shoot, Changchun Changsheng Bio-technology, have been told by China’s drug watchdog to stop production of its rabies vaccines, reports South China Morning Post

An inspection by the watchdog uncovered that the country’s second-largest producer of rabies vaccines had been forging data and violating protocol in the production of Vero-cell rabies vaccines in Changchun.

According to the World Health Organization, rabies is endemic, with 96 percent of deaths via the disease occurring in Asia and Africa. The fatal virus is spread to people from the saliva of rabid animals into wounds or bites. After infection, the virus can be treated through shots.

In a statement on July 15, the Chinese Drug State Administration said it ordered the Changchun branch to revoke an important production license.

The administration confirmed that no vaccine products involved in the recent inspection were on sale, and all vaccines involved have been removed.

READ MORE: Vaccine Shortages Stir Parental Panic In Guangdong

Changsheng Life Sciences, Changchun and its Shenzhen-listed parent company made a statement on July 16 that the company had voluntarily recalled and sealed all the rabies vaccines that had been already sent to disease control centers and hospitals.

This is not the first scandal for the company – less than a year ago the company’s DPT vaccine, which prevents diphtheria, whooping cough and tetanus, was discovered to be not up to standard. The company had sold hundreds of thousands of vaccines from the substandard batch to disease and control prevention centers in Shandong province.

Despite the recent recall, the company defended the quality of its previous rabies vaccines, saying, “no adverse effects related to the quality of the vaccine have been found from years of adverse effects monitoring.”

READ MORE: Massive Vaccine Scandal Rocks China 

[Cover image via Pexels

more news

China Has Administered 1 Billion COVID-19 Vaccine Doses

It is quite a milestone for a country that got off to a slow start with its mass vaccination drive.

3-Year-Olds to Be Given COVID-19 Vaccine in China

Health officials announced the emergency approval of vaccines for 3 to 17 year olds.

China Has Administered 400 Million COVID-19 Vaccine Doses

China's NHC reported that more than 406.9 million doses of COVID-19 vaccines have been administered.

China Releases New Vaccine and Testing Regulations for Visa Applicants

Those who received Pfizer, Moderna, or Johnson & Johnson vaccines will also have to take nucleocapsid (N) protein tests.

Getting a China-produced Vaccine May Help Your Visa Application

Visa rules for citizens of some countries will be eased on condition that applicants take China-produced vaccines.

6 Foreign Teachers Receive China's COVID-19 Vaccine

Foreign teachers discuss why they took the vaccine.

Who Has Priority for China's COVID-19 Vaccine?

The Sinopharm COVID-19 vaccine will first be available to nine priority groups.

0 User Comments

In Case You Missed It…

We're on WeChat!

Scan our QR Code at right or follow us at ThatsShenzhen for events, guides, giveaways and much more!

7 Days in Shenzhen With thatsmags.com

Weekly updates to your email inbox every Wednesday

Subscribe

Download previous issues

Never miss an issue of That's !

Visit the archives